IRVINGTON, NY -- (MARKET WIRE) -- March 28, 2007 -- Electro Optical Sciences, Inc. (“EOS”) (NASDAQ: MELA) today announced the signing of an agreement with L’Oreal to study and assess the feasibility of using EOS’ novel multi-spectral imaging technology for the evaluation and differentiation of pigmented skin lesions of cosmetic importance. EOS has granted L’Oreal an option to take an exclusive license to use EOS technology in the field covered by the research, on terms to be mutually agreed. The laboratory and clinical research will be funded by L’Oreal.
